IRIS
SIGNORIELLO, ELISABETTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 219
AS - Asia 109
EU - Europa 73
AF - Africa 11
OC - Oceania 2
Totale 414
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 219
SG - Singapore 47
IT - Italia 35
HK - Hong Kong 34
IN - India 14
CI - Costa d'Avorio 11
GB - Regno Unito 10
CN - Cina 9
RU - Federazione Russa 5
DE - Germania 4
NL - Olanda 4
UA - Ucraina 4
IR - Iran 3
SE - Svezia 3
BE - Belgio 2
FI - Finlandia 2
AT - Austria 1
AU - Australia 1
CH - Svizzera 1
IE - Irlanda 1
LT - Lituania 1
MY - Malesia 1
NZ - Nuova Zelanda 1
VN - Vietnam 1
Totale 414
Salva come PNG Salva come JPEG
Città #
Santa Clara 37
Chandler 36
Singapore 36
Hong Kong 34
Ashburn 26
Naples 11
Boston 6
Lawrence 6
Millbury 5
Des Moines 4
Rome 4
Seattle 3
Amsterdam 2
Aversa 2
Brussels 2
Dallas 2
Lappeenranta 2
Redhill 2
Washington 2
Woodbridge 2
Ardabil 1
Augusta 1
Beijing 1
Brookfield 1
Cambridge 1
Campo San Martino 1
Changzhou 1
Cyberjaya 1
Dublin 1
Faenza 1
Fairfield 1
Frankfurt am Main 1
Genoa 1
Gurgaon 1
Hefei 1
Ho Chi Minh City 1
Nanjing 1
Pingxiang 1
Pune 1
Stockholm 1
Sydney 1
Torre del Greco 1
Vienna 1
Villarsiviriaux 1
Wellington 1
Wilmington 1
Zhengzhou 1
Totale 251
Salva come PNG Salva come JPEG
Nome #
Clinical and 3D instrumental assessment of the short-term effect of Sativex on patients with multiple sclerosis 59
Adiponectin in Cerebrospinal Fluid from Patients Affected by Multiple Sclerosis Is Correlated with the Progression and Severity of Disease 43
Multiple sclerosis and genetic polymorphisms in fibrinogen-mediated hemostatic pathways: a case–control study 42
Unraveling diagnostic uncertainty in transition phase from relapsing-remitting to secondary progressive multiple sclerosis 40
Prognostic Markers of Ocrelizumab Effectiveness in Multiple Sclerosis: A Real World Observational Multicenter Study 39
Correction to: Adiponectin in Cerebrospinal Fluid from Patients Affected by Multiple Sclerosis Is Correlated with the Progression and Severity of Disease 39
Alemtuzumab significantly improves posterior fossa syndrome presented as a relapse of multiple sclerosis 35
Signs and symptoms of COVID-19 in patients with multiple sclerosis 27
Validation of an iPad version of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) 23
Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy 21
A real-world study of alemtuzumab in a cohort of Italian patients 20
Adiponectin Alleviates Cell Injury due to Cerebrospinal Fluid from Multiple Sclerosis Patients by Inhibiting Oxidative Stress and Proinflammatory Response 20
Antibody response elicited by the SARS-CoV-2 vaccine booster in patients with multiple sclerosis: Who gains from it? 12
Impact of Lifestyle Interventions on Multiple Sclerosis: Focus on Adipose Tissue 10
Ocrelizumab Alters Cytotoxic Lymphocyte Function While Reducing EBV-Specific CD8 + T-Cell Proliferation in Patients With Multiple Sclerosis 9
Innovative multidisciplinary tool for screening bowel and bladder symptoms in multiple sclerosis 4
Totale 443
Salva come PNG Salva come JPEG
Categoria #
all - tutte 2.656
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.656
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202137 0 0 0 4 0 1 0 0 7 20 5 0
2021/202249 2 0 0 4 0 2 0 1 0 10 15 15
2022/202387 6 3 1 3 15 16 4 11 19 2 3 4
2023/2024100 3 8 4 6 12 21 2 12 1 4 20 7
2024/2025170 25 12 5 7 29 45 47 0 0 0 0 0
Totale 443